Search

Your search keyword '"Khakoo Y"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Khakoo Y" Remove constraint Author: "Khakoo Y" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
126 results on '"Khakoo Y"'

Search Results

2. Immunotherapy: DISCOVERY PROTEOMICS FOR ANALYTES TO PREDICT CYTOKINE RELEASE SYNDROME ON DAY OF INFUSION OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS

3. PREDICTORS FOR NEUROTOXICITY on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform

6. MEDULLOBLASTOMA

7. HIGH GRADE GLIOMAS AND DIPG

9. CLIN-PEDIATRICS CLINICAL RESEARCH

10. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

11. RADIOLOGY

12. GERM CELL TUMORS

22. Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.

23. 525 - Immunotherapy: DISCOVERY PROTEOMICS FOR ANALYTES TO PREDICT CYTOKINE RELEASE SYNDROME ON DAY OF INFUSION OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS.

24. Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes.

25. Analysis of Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society.

26. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.

27. Pediatric Neurology in the Post-Roe Era.

29. Pediatric Postmortem Tissue Donation in the Confines of a Pandemic: A Model of Collaboration.

30. An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome Registry and Clinical Research Network: Development, Progress, and Vision.

32. Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients.

34. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.

37. Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding.

38. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.

39. Neuro-Oncology Training for the Child Neurology Resident.

40. An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy.

41. Trainee Award Announcement.

42. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.

43. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

44. Medulloblastoma: an Old Diagnosis with New Promises.

45. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.

47. Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.

48. New insights into neurocutaneous melanosis.

50. The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis.

Catalog

Books, media, physical & digital resources